These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 2122546)
41. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Cervera R; Font J; López-Soto A; Casals F; Pallarés L; Bové A; Ingelmo M; Urbano-Márquez A Ann Rheum Dis; 1990 Feb; 49(2):109-13. PubMed ID: 2107799 [TBL] [Abstract][Full Text] [Related]
42. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Matsuda J; Saitoh N; Gohchi K; Gotoh M; Tsukamoto M Am J Hematol; 1994 Sep; 47(1):56-8. PubMed ID: 8042617 [TBL] [Abstract][Full Text] [Related]
43. Haemostatic factors associated with vascular thrombosis in patients with systemic lupus erythematosus and the lupus anticoagulant. Mayumi T; Nagasawa K; Inoguchi T; Yamauchi Y; Ishii Y; Tada Y; Umeda F; Niho Y Ann Rheum Dis; 1991 Aug; 50(8):543-7. PubMed ID: 1909517 [TBL] [Abstract][Full Text] [Related]
44. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Harris EN; Gharavi AE; Boey ML; Patel BM; Mackworth-Young CG; Loizou S; Hughes GR Lancet; 1983 Nov; 2(8361):1211-4. PubMed ID: 6139567 [TBL] [Abstract][Full Text] [Related]
46. Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies. Obermoser G; Bitterlich W; Kunz F; Sepp NT Int Arch Allergy Immunol; 2004 Oct; 135(2):148-53. PubMed ID: 15345914 [TBL] [Abstract][Full Text] [Related]
47. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study. Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663 [TBL] [Abstract][Full Text] [Related]
48. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus. Bertolaccini ML; Mepani K; Sanna G; Hughes GR; Khamashta MA Ann Rheum Dis; 2007 Apr; 66(4):533-6. PubMed ID: 17020907 [TBL] [Abstract][Full Text] [Related]
49. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome. Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980 [TBL] [Abstract][Full Text] [Related]
50. Recurrent cerebral ischemia and mitral valve vegetation in a patient with antiphospholipid antibodies. Anderson D; Bell D; Lodge R; Grant E J Rheumatol; 1987 Aug; 14(4):839-41. PubMed ID: 3118020 [TBL] [Abstract][Full Text] [Related]
51. Lupus anticoagulant: revival of an old phenomenon. Derksen RH; Kater L Clin Exp Rheumatol; 1985; 3(4):349-57. PubMed ID: 3910324 [TBL] [Abstract][Full Text] [Related]
52. Testing strategies for diagnosing lupus anticoagulant: decision analysis. Segal JB; Lehmann HP; Petri M; Mueller L; Kickler TS Am J Hematol; 2002 Jul; 70(3):195-205. PubMed ID: 12111765 [TBL] [Abstract][Full Text] [Related]
53. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792 [TBL] [Abstract][Full Text] [Related]
54. Studies of natural anticoagulant proteins and anticardiolipin antibodies in patients with the lupus anticoagulant. Lo SC; Salem HH; Howard MA; Oldmeadow MJ; Firkin BG Br J Haematol; 1990 Nov; 76(3):380-6. PubMed ID: 2175638 [TBL] [Abstract][Full Text] [Related]